• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性及布西拉明诱导的膜性肾病中肾小球蛋白质的比较蛋白质组学分析

Comparative proteomic analysis of glomerular proteins in primary and bucillamine-induced membranous nephropathy.

作者信息

Kaga Hajime, Matsumura Hirotoshi, Suzuki Takehiro, Dohmae Naoshi, Odaka Masafumi, Komatsuda Atsushi, Takahashi Naoto, Wakui Hideki

机构信息

Department of Hematology, Nephrology, and Rheumatology, Akita University Graduate School of Medicine, Akita, Japan.

Department of Life Science, Graduate School of Engineering Science, Akita University, 1-1 Tegatagakuen-machi, Akita City, Akita, 010-8502, Japan.

出版信息

Clin Proteomics. 2022 Jul 14;19(1):26. doi: 10.1186/s12014-022-09365-x.

DOI:10.1186/s12014-022-09365-x
PMID:35836124
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9281048/
Abstract

BACKGROUND

Anti-phospholipase A2 receptor autoantibody (PLA2R Ab)-associated membranous nephropathy (MN) is the most common form of primary MN (pMN). On the other hand, bucillamine (BCL), an antirheumatic drug developed in Japan, was reported to cause a rare form of secondary MN (sMN). Between these MN forms, comparative proteomic analysis of glomerular proteins has not been performed.

METHODS

We used renal biopsy specimens from 6 patients with PLA2R Ab (+) pMN, 6 patients with PLA2R Ab (‒) pMN, 6 patients with BCL-induced sMN, and 5 control cases (time 0 transplant biopsies). Proteins were extracted from laser-microdissected glomeruli and analyzed using mass spectrometry. The quantification values of protein abundance in each MN group were compared with those in the control group.

RESULTS

More than 800 proteins with high confidence were identified. Principal component analysis revealed a different distribution between the pMN and sMN groups. For further analysis, 441 proteins matched with ≥ 3 peptides were selected. Among the pMN and sMN groups, we compared the profiles of several protein groups based on the structural and functional characteristics, such as immunoglobulins, complements, complement-regulating proteins, podocyte-associated proteins, glomerular basement membrane proteins, and several proteins that are known to be associated with kidney diseases, including MN. In all MN groups, increased levels of immunoglobulins (IgG, IgA, and IgM), complements (C3, C4, and C9), complement factor H-related protein 5, type XVIII collagen, calmodulin, polyubiquitin, and ubiquitin ligase were observed. For some proteins, such as type VII collagen and nestin, the fold-change values were significantly different between the pMN and sMN groups.

CONCLUSIONS

Between the pMN and BCL-induced sMN groups, we observed common and different alterations in protein levels such as known disease-associated proteins and potential disease marker proteins.

摘要

背景

抗磷脂酶A2受体自身抗体(PLA2R Ab)相关的膜性肾病(MN)是原发性MN(pMN)最常见的形式。另一方面,布西拉明(BCL)是一种在日本研发的抗风湿药物,据报道可导致一种罕见的继发性MN(sMN)形式。在这些MN形式之间,尚未对肾小球蛋白进行比较蛋白质组学分析。

方法

我们使用了6例PLA2R Ab(+)pMN患者、6例PLA2R Ab(-)pMN患者、6例BCL诱导的sMN患者的肾活检标本以及5例对照病例(移植时0期活检)。从激光显微切割的肾小球中提取蛋白质,并使用质谱进行分析。将每个MN组中蛋白质丰度的定量值与对照组进行比较。

结果

鉴定出800多种可信度高的蛋白质。主成分分析显示pMN组和sMN组之间存在不同的分布。为了进一步分析,选择了441种与≥3个肽段匹配的蛋白质。在pMN组和sMN组中,我们根据结构和功能特征比较了几个蛋白质组的谱,如免疫球蛋白、补体、补体调节蛋白、足细胞相关蛋白、肾小球基底膜蛋白以及几种已知与肾脏疾病(包括MN)相关的蛋白质。在所有MN组中,均观察到免疫球蛋白(IgG、IgA和IgM)、补体(C3、C4和C9)、补体因子H相关蛋白5、 XVIII型胶原、钙调蛋白、多聚泛素和泛素连接酶水平升高。对于某些蛋白质,如VII型胶原和巢蛋白,pMN组和sMN组之间的倍数变化值存在显著差异。

结论

在pMN组和BCL诱导的sMN组之间,我们观察到蛋白质水平存在共同和不同的变化,如已知的疾病相关蛋白和潜在的疾病标志物蛋白。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aca1/9281048/a1772cfc30ca/12014_2022_9365_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aca1/9281048/a1772cfc30ca/12014_2022_9365_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aca1/9281048/a1772cfc30ca/12014_2022_9365_Fig1_HTML.jpg

相似文献

1
Comparative proteomic analysis of glomerular proteins in primary and bucillamine-induced membranous nephropathy.原发性及布西拉明诱导的膜性肾病中肾小球蛋白质的比较蛋白质组学分析
Clin Proteomics. 2022 Jul 14;19(1):26. doi: 10.1186/s12014-022-09365-x.
2
Clinical significance of Mtype phospholipase A2 receptor and thrombospondin Type 1 domaincontaining 7A in primary membranous nephropathy.M型磷脂酶A2受体和含血小板反应蛋白1结构域7A在原发性膜性肾病中的临床意义
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2020 Jun 28;45(6):693-700. doi: 10.11817/j.issn.1672-7347.2020.190109.
3
Retrospective Study of Phospholipase A2 Receptor and IgG Subclasses in Glomerular Deposits in Chinese Patients with Membranous Nephropathy.中国膜性肾病患者肾小球沉积物中磷脂酶A2受体及IgG亚类的回顾性研究
PLoS One. 2016 May 25;11(5):e0156263. doi: 10.1371/journal.pone.0156263. eCollection 2016.
4
Proteomic Analysis of Complement Proteins in Membranous Nephropathy.膜性肾病中补体蛋白的蛋白质组学分析
Kidney Int Rep. 2020 Jan 30;5(5):618-626. doi: 10.1016/j.ekir.2020.01.018. eCollection 2020 May.
5
Comparative proteomic analysis of glomerular proteins in IgA nephropathy and IgA vasculitis with nephritis.IgA肾病和IgA血管炎伴肾炎肾小球蛋白的比较蛋白质组学分析
Clin Proteomics. 2023 May 13;20(1):21. doi: 10.1186/s12014-023-09409-w.
6
Serum secretory phospholipase A2 group IB correlates with the severity of membranous nephropathy.血清分泌型磷脂酶 A2 组 IB 与膜性肾病的严重程度相关。
Clin Chim Acta. 2018 Jul;482:178-184. doi: 10.1016/j.cca.2018.04.009. Epub 2018 Apr 9.
7
Establishing a Case for Anti-complement Therapy in Membranous Nephropathy.确立膜性肾病抗补体治疗的依据
Kidney Int Rep. 2020 Dec 13;6(2):484-492. doi: 10.1016/j.ekir.2020.11.032. eCollection 2021 Feb.
8
Clinical value of a serum anti-PLA2R antibody in the diagnosis and monitoring of primary membranous nephropathy in adults.血清抗磷脂酶A2受体抗体在成人原发性膜性肾病诊断及监测中的临床价值
Int J Nephrol Renovasc Dis. 2018 Sep 20;11:241-247. doi: 10.2147/IJNRD.S176665. eCollection 2018.
9
A pilot and comparative study between pathological and serological levels of immunoglobulin and complement among three kinds of primary glomerulonephritis.一种原发性肾小球肾炎三种类型免疫球蛋白和补体的病理与血清学水平的初步对比研究。
BMC Immunol. 2018 Jun 20;19(1):18. doi: 10.1186/s12865-018-0254-z.
10
Diagnostic specificity of autoantibodies to M-type phospholipase A2 receptor (PLA2R) in differentiating idiopathic membranous nephropathy (IMN) from secondary forms and other glomerular diseases.抗 M 型磷脂酶 A2 受体 (PLA2R) 自身抗体在鉴别特发性膜性肾病 (IMN) 与继发性及其他肾小球疾病中的诊断特异性。
J Nephrol. 2018 Apr;31(2):271-278. doi: 10.1007/s40620-017-0451-5. Epub 2017 Oct 28.

引用本文的文献

1
Bucillamine-induced membranous nephropathy versus primary membranous nephropathy: comparing pathological features and kidney prognosis.青霉胺诱导的膜性肾病与原发性膜性肾病:病理特征及肾脏预后比较
Sci Rep. 2025 Mar 6;15(1):7869. doi: 10.1038/s41598-025-92465-z.
2
Detection of N‑glycoprotein associated with IgA nephropathy in urine as a potential diagnostic biomarker using glycosylated proteomic analysis.利用糖基化蛋白质组学分析检测尿液中与IgA肾病相关的N-糖蛋白作为潜在的诊断生物标志物。
Exp Ther Med. 2023 Aug 23;26(4):478. doi: 10.3892/etm.2023.12177. eCollection 2023 Oct.
3
Comparative proteomic analysis of glomerular proteins in IgA nephropathy and IgA vasculitis with nephritis.

本文引用的文献

1
Secondary Membranous Nephropathy. A Narrative Review.继发性膜性肾病。一篇综述。
Front Med (Lausanne). 2020 Dec 3;7:611317. doi: 10.3389/fmed.2020.611317. eCollection 2020.
2
Complexities of the glomerular basement membrane.肾小球基底膜的复杂性。
Nat Rev Nephrol. 2021 Feb;17(2):112-127. doi: 10.1038/s41581-020-0329-y. Epub 2020 Aug 24.
3
Podocytopathies.足细胞病。
IgA肾病和IgA血管炎伴肾炎肾小球蛋白的比较蛋白质组学分析
Clin Proteomics. 2023 May 13;20(1):21. doi: 10.1186/s12014-023-09409-w.
Nat Rev Dis Primers. 2020 Aug 13;6(1):68. doi: 10.1038/s41572-020-0196-7.
4
Regulation of the Actin Cytoskeleton in Podocytes.足细胞中肌动蛋白细胞骨架的调节。
Cells. 2020 Jul 16;9(7):1700. doi: 10.3390/cells9071700.
5
Comparative proteomic analysis of renal proteins from IgA nephropathy model mice and control mice.IgA 肾病模型小鼠与对照小鼠肾组织蛋白质的比较蛋白质组学分析。
Clin Exp Nephrol. 2020 Aug;24(8):666-679. doi: 10.1007/s10157-020-01898-5. Epub 2020 May 20.
6
Proteomic Analysis of Complement Proteins in Membranous Nephropathy.膜性肾病中补体蛋白的蛋白质组学分析
Kidney Int Rep. 2020 Jan 30;5(5):618-626. doi: 10.1016/j.ekir.2020.01.018. eCollection 2020 May.
7
Chronic kidney disease: a review of proteomic and metabolomic approaches to membranous glomerulonephritis, focal segmental glomerulosclerosis, and IgA nephropathy biomarkers.慢性肾脏病:膜性肾小球肾炎、局灶节段性肾小球硬化症和IgA肾病生物标志物的蛋白质组学和代谢组学方法综述
Proteome Sci. 2019 Dec 20;17:7. doi: 10.1186/s12953-019-0155-y. eCollection 2019.
8
Proteomics of human glomerulonephritis by laser microdissection and liquid chromatography-tandem mass spectrometry.应用激光微切割和液相色谱-串联质谱技术对人肾小球肾炎的蛋白质组学研究。
Nephrology (Carlton). 2020 Apr;25(4):351-359. doi: 10.1111/nep.13676. Epub 2019 Dec 9.
9
The anti-PLA2R antibody in membranous nephropathy: what we know and what remains a decade after its discovery.膜性肾病中的抗 PLA2R 抗体:发现后的十年,我们的所知与未解。
Kidney Int. 2019 Dec;96(6):1292-1302. doi: 10.1016/j.kint.2019.07.014. Epub 2019 Aug 12.
10
Application of miR-193a/WT1/PODXL axis to estimate risk and prognosis of idiopathic membranous nephropathy.miR-193a/WT1/PODXL 轴在特发性膜性肾病风险和预后评估中的应用。
Ren Fail. 2019 Nov;41(1):704-717. doi: 10.1080/0886022X.2019.1642210.